Concord Wealth Partners - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 23 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$98,066
-25.9%
15,275
-14.1%
0.02%
-44.7%
Q1 2023$132,424
+70.5%
17,7750.0%0.04%
+65.2%
Q4 2022$77,677
-22.3%
17,7750.0%0.02%
-28.1%
Q3 2022$100,000
-2.9%
17,7750.0%0.03%
+14.3%
Q2 2022$103,000
-39.4%
17,775
+6.0%
0.03%
-36.4%
Q1 2022$170,000
+60.4%
16,775
+31.3%
0.04%
+69.2%
Q4 2021$106,00012,7750.03%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,198,000$6,733,0007.35%
K.J. Harrison & Partners Inc 479,838$2,748,0000.97%
SABBY MANAGEMENT, LLC 94,005$528,0000.67%
Redmond Asset Management, LLC 137,689$774,0000.29%
Concord Wealth Partners 17,775$100,0000.03%
Virtu Financial LLC 48,347$272,0000.02%
Caption Management, LLC 177,000$996,0000.01%
WASATCH ADVISORS LP 353,744$1,988,0000.01%
Summit Trail Advisors, LLC 35,000$197,0000.01%
BLUEFIN CAPITAL MANAGEMENT, LLC 17,546$99,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders